104 Telithromycin PPTs View free & download

TELITHROMYCIN SAFETY UPDATE PowerPoint PPT Presentation

TELITHROMYCIN SAFETY UPDATE - Patients with myasthenia gravis should not take KETEK, unless there are no other ... Exacerbations of myasthenia gravis have been reported in patients treated ...

Patients with myasthenia gravis should not take KETEK, unless there are no other ... Exacerbations of myasthenia gravis have been reported in patients treated ...

| PowerPoint PPT presentation | free to download

Telithromycin Ketek: General Safety Profile - Concentration- and dose-dependent in QTc. QTc increase comparable to cisapride ... Concentration increased by 3A4 inhibitor. PK variability seen ...

Concentration- and dose-dependent in QTc. QTc increase comparable to cisapride ... Concentration increased by 3A4 inhibitor. PK variability seen ...

| PowerPoint PPT presentation | free to view

Clinical Assessment of Liver Toxicity Due to Telithromycin (Ketek PowerPoint PPT Presentation

Clinical Assessment of Liver Toxicity Due to Telithromycin (Ketek - UT Southwestern Medical Center. Dallas, TX. www.acuteliverfailure.org. December 14, 2006 ... UT Southwestern Medical Center at Dallas ...

UT Southwestern Medical Center. Dallas, TX. www.acuteliverfailure.org. December 14, 2006 ... UT Southwestern Medical Center at Dallas ...

| PowerPoint PPT presentation | free to view

DrugResistant Tuberculosis PowerPoint PPT Presentation

DrugResistant Tuberculosis - Treatment of tuberculosis: guidelines for national ... Imidazole derivatives : PA824. Diaryquinolone : TMC207. Ketolides : telithromycin (no activities) ...

Treatment of tuberculosis: guidelines for national ... Imidazole derivatives : PA824. Diaryquinolone : TMC207. Ketolides : telithromycin (no activities) ...

| PowerPoint PPT presentation | free to view

FDA Advisory Committee April 26, 2001 PowerPoint PPT Presentation

FDA Advisory Committee April 26, 2001 - MM-6. Recognition of Clinical Relevance of Erythromycin ... MM-12. Telithromycin ... MM-14. Benefits of Carbamate Residue and Side Chain at Position C11 C12 ...

MM-6. Recognition of Clinical Relevance of Erythromycin ... MM-12. Telithromycin ... MM-14. Benefits of Carbamate Residue and Side Chain at Position C11 C12 ...

| PowerPoint PPT presentation | free to download

Aseptic Meningitis By: Seth Yandell PowerPoint PPT Presentation

Aseptic Meningitis By: Seth Yandell - Aseptic Meningitis By: Seth Yandell Case Presentation HPI: 31 y/o WF who 3 days prior to presentation had finished a 5 day course of Telithromycin prescribed by her ...

Aseptic Meningitis By: Seth Yandell Case Presentation HPI: 31 y/o WF who 3 days prior to presentation had finished a 5 day course of Telithromycin prescribed by her ...

| PowerPoint PPT presentation | free to download

Large Comparative Safety Trial in an Usual Care Setting ____________________________________________ PowerPoint PPT Presentation

Large Comparative Safety Trial in an Usual Care Setting ____________________________________________ - Comparator: Amoxicillin-clavulanic acid (AMC) 875 mg/125 mg bid x 7-10 days for ... Telithromycin appeared similar to AMC with elevations in hepatic analytes ...

Comparator: Amoxicillin-clavulanic acid (AMC) 875 mg/125 mg bid x 7-10 days for ... Telithromycin appeared similar to AMC with elevations in hepatic analytes ...

| PowerPoint PPT presentation | free to download

Pre-Approval Efficacy and Safety Data PowerPoint PPT Presentation

Pre-Approval Efficacy and Safety Data - Pre-Approval. Efficacy and Safety Data. John Alexander M.D., M.P.H.. Medical Team Leader ... Acute Exacerbation of Chronic Bronchitis (AECB) Acute Bacterial ...

Pre-Approval. Efficacy and Safety Data. John Alexander M.D., M.P.H.. Medical Team Leader ... Acute Exacerbation of Chronic Bronchitis (AECB) Acute Bacterial ...

| PowerPoint PPT presentation | free to download

Ketek - One Study in the Resubmission. Study 3013 ... with 1st Review Cycle. Study 3002 ... 7 Comparator Patients with DRSP. 2 Isolates Susceptible to ...

One Study in the Resubmission. Study 3013 ... with 1st Review Cycle. Study 3002 ... 7 Comparator Patients with DRSP. 2 Isolates Susceptible to ...

| PowerPoint PPT presentation | free to download

FDA Advisory Committee January 8, 2003 PowerPoint PPT Presentation

FDA Advisory Committee January 8, 2003 - W. Craig, MD, University of Wisconsin, Madison, WI ... b Lonks et al. CID 2002, Kelly et al. CID. 2000. c Davidson et al. NEJM. 2002, Urban et al. JID. ...

W. Craig, MD, University of Wisconsin, Madison, WI ... b Lonks et al. CID 2002, Kelly et al. CID. 2000. c Davidson et al. NEJM. 2002, Urban et al. JID. ...

| PowerPoint PPT presentation | free to view

Ketolides Market Size, Share, Trends And Forecast To 2033 PowerPoint PPT Presentation

Ketolides Market Size, Share, Trends And Forecast To 2033 - Global ketolides market size is expected at$3.82 bn by 2028 at a growth rate of of 4.4% by The Business Research Company.

Global ketolides market size is expected at$3.82 bn by 2028 at a growth rate of of 4.4% by The Business Research Company.

| PowerPoint PPT presentation | free to download

Streptococcus pneumoniae and Antibiotics Resistance' The EQUERE Project Quebec 19982004 PowerPoint PPT Presentation

Streptococcus pneumoniae and Antibiotics Resistance' The EQUERE Project Quebec 19982004 - Number of Strains and Demographic Characteristics. 1306 41.1% 1880 58.9% 2245 70.5 ... Dr Maryse Cayouette: Centre Hospitalier r gional de Lanaudi re, Joliette. ...

Number of Strains and Demographic Characteristics. 1306 41.1% 1880 58.9% 2245 70.5 ... Dr Maryse Cayouette: Centre Hospitalier r gional de Lanaudi re, Joliette. ...

| PowerPoint PPT presentation | free to view

Overview of Antimicrobials PowerPoint PPT Presentation

Overview of Antimicrobials - Overview of Antimicrobials Dr W.D. Colby Microbiology & Immunology Classes of Antimicrobials -lactams Aminoglycosides Extended macrolide family Glycopeptides ...

Overview of Antimicrobials Dr W.D. Colby Microbiology & Immunology Classes of Antimicrobials -lactams Aminoglycosides Extended macrolide family Glycopeptides ...

| PowerPoint PPT presentation | free to view

... (Bottom) of Cases of MRSA Infection among St. Louis Ram PowerPoint PPT Presentation

... (Bottom) of Cases of MRSA Infection among St. Louis Ram - ... (Bottom) of Cases of MRSA Infection among St. Louis Rams Football Players in 2003 ... Scottish, Irish. TNFR. type 1. TNFRSF1A. 12p13. AD. Jewish, Turkish, ...

... (Bottom) of Cases of MRSA Infection among St. Louis Rams Football Players in 2003 ... Scottish, Irish. TNFR. type 1. TNFRSF1A. 12p13. AD. Jewish, Turkish, ...

| PowerPoint PPT presentation | free to view

Clarithromycin Subject 40033212003 with ERSP Isolates, PPb PowerPoint PPT Presentation

Clarithromycin Subject 40033212003 with ERSP Isolates, PPb - 51 year old female, Fine Score II, no relevant risk factors for pneumonia ... Day 6: pneumonia worsened with development of septic arthritis. ...

51 year old female, Fine Score II, no relevant risk factors for pneumonia ... Day 6: pneumonia worsened with development of septic arthritis. ...

| PowerPoint PPT presentation | free to view

Mycoplasma ve Chlamydophila PowerPoint PPT Presentation

Mycoplasma ve Chlamydophila - Title: No Slide Title Author: Dr Woodhead Last modified by: Any authorised employee Created Date: 11/8/2000 11:24:44 AM Document presentation format

Title: No Slide Title Author: Dr Woodhead Last modified by: Any authorised employee Created Date: 11/8/2000 11:24:44 AM Document presentation format

| PowerPoint PPT presentation | free to view

Vancomycin - In many vancomycin-resistant strains of enterococci, the D-alanyl-D-alanine ... Thus, E. coli O157 (the Jack-in-the-Box and Stock Pavillion E. coli) is #157 of ...

In many vancomycin-resistant strains of enterococci, the D-alanyl-D-alanine ... Thus, E. coli O157 (the Jack-in-the-Box and Stock Pavillion E. coli) is #157 of ...

| PowerPoint PPT presentation | free to download

Macrolide Antibiotics and Torsade de Pointes Postmarketing Analysis PowerPoint PPT Presentation

Macrolide Antibiotics and Torsade de Pointes Postmarketing Analysis - Iatrogenic QT Prolongation and Torsade de Pointes. Adverse Events in the ... Recognition of the potential for Torsade de Pointes should clearly be acknowledged. ...

Iatrogenic QT Prolongation and Torsade de Pointes. Adverse Events in the ... Recognition of the potential for Torsade de Pointes should clearly be acknowledged. ...

| PowerPoint PPT presentation | free to view

Gram-positive bacteria: Staphylococci PowerPoint PPT Presentation

Gram-positive bacteria: Staphylococci - Gram-positive bacteria: Staphylococci Staphylococcus aureus Staphylococcus aureus http://www.visualdxhealth.com/pdfs/MRSA%20Handout.pdf Superantigens http://highered ...

Gram-positive bacteria: Staphylococci Staphylococcus aureus Staphylococcus aureus http://www.visualdxhealth.com/pdfs/MRSA%20Handout.pdf Superantigens http://highered ...

| PowerPoint PPT presentation | free to download

CEPHALOSPORINS PowerPoint PPT Presentation

CEPHALOSPORINS - Cefadroxil, cephalexin. Cefazolin. First-generation. Oral Agents. Parenteral ... include Cefazolin (parenteral) as well as cefadroxil and cephalexin (oral) ...

Cefadroxil, cephalexin. Cefazolin. First-generation. Oral Agents. Parenteral ... include Cefazolin (parenteral) as well as cefadroxil and cephalexin (oral) ...

| PowerPoint PPT presentation | free to download

b-Lactamase Inhibitors PowerPoint PPT Presentation

b-Lactamase Inhibitors - Powerful irreversible inhibitor of b-lactamases - suicide substrate ... Exists as a zwitterion and is soluble in water. Poorly absorbed through the gut wall ...

Powerful irreversible inhibitor of b-lactamases - suicide substrate ... Exists as a zwitterion and is soluble in water. Poorly absorbed through the gut wall ...

| PowerPoint PPT presentation | free to download

Chapter 8 Antibiotics PowerPoint PPT Presentation

Chapter 8 Antibiotics - Chapter 8 Antibiotics Section 2. Tetracyclines Section 3. Aminoglycoside Section 4. Macrolides Section 5. Chloramphenicol Tetracycline Antibiotics Tetracycline ...

Chapter 8 Antibiotics Section 2. Tetracyclines Section 3. Aminoglycoside Section 4. Macrolides Section 5. Chloramphenicol Tetracycline Antibiotics Tetracycline ...

| PowerPoint PPT presentation | free to view

Inhibitory and bactericidal concentrations of current and new antibiotics for Methicillin-resistant Staphylococcal ocular infections PowerPoint PPT Presentation

Inhibitory and bactericidal concentrations of current and new antibiotics for Methicillin-resistant Staphylococcal ocular infections - Inhibitory and bactericidal concentrations of current and new antibiotics for Methicillin-resistant Staphylococcal ocular infections Yousuf Qureshi, M.D.

Inhibitory and bactericidal concentrations of current and new antibiotics for Methicillin-resistant Staphylococcal ocular infections Yousuf Qureshi, M.D.

| PowerPoint PPT presentation | free to download

Pregabalin Capsules & Azithromycin Tablets manufacturer supplier & exporter in India PowerPoint PPT Presentation

Pregabalin Capsules & Azithromycin Tablets manufacturer supplier & exporter in India - JoinHub Pharma is a WHO-GMP & EU-GMP certified Pregabalin Capsules manufacturer, supplier & exporter based in India. Contact us now. JoinHub Pharma is a WHO-GMP & EU-GMP certified Azithromycin Tablets manufacturer, supplier & exporter based in India. Contact us now.

JoinHub Pharma is a WHO-GMP & EU-GMP certified Pregabalin Capsules manufacturer, supplier & exporter based in India. Contact us now. JoinHub Pharma is a WHO-GMP & EU-GMP certified Azithromycin Tablets manufacturer, supplier & exporter based in India. Contact us now.

| PowerPoint PPT presentation | free to download

U.S. Food and Drug Administration PowerPoint PPT Presentation

U.S. Food and Drug Administration - 2) Sole therapy or one of few alternatives to treat serious human disease or ... Treatment recommended in patients with more severe forms of disease like ...

2) Sole therapy or one of few alternatives to treat serious human disease or ... Treatment recommended in patients with more severe forms of disease like ...

| PowerPoint PPT presentation | free to view

b-Lactamase Inhibitors - Modest activity against Staphylococcus aureus Gram-negative bacteria Escherichia coli, Klebsiella pneumoniae, Proteus spp. Haemophilus influenzae, Neisseria spp.

Modest activity against Staphylococcus aureus Gram-negative bacteria Escherichia coli, Klebsiella pneumoniae, Proteus spp. Haemophilus influenzae, Neisseria spp.

| PowerPoint PPT presentation | free to download

Ketek, FDA Hearing, PowerPoint PPT Presentation

Ketek, FDA Hearing, - The application for renewal of the MA was assessed in parallell with the re ... The Marketing Authorization was renewed by the EU-commission in July 2006, based ...

The application for renewal of the MA was assessed in parallell with the re ... The Marketing Authorization was renewed by the EU-commission in July 2006, based ...

| PowerPoint PPT presentation | free to download

Protein binding and tissue concentrations PowerPoint PPT Presentation

Protein binding and tissue concentrations - 8th ISAP Educational Workshop, Glasgow 2003 Protein binding and tissue concentrations do they matter ? Ursula Theuretzbacher Antibiotic Center, Vienna

8th ISAP Educational Workshop, Glasgow 2003 Protein binding and tissue concentrations do they matter ? Ursula Theuretzbacher Antibiotic Center, Vienna

| PowerPoint PPT presentation | free to view

Definitions - Definitions Bacteremia: Presence of bacteria in the blood Under normal circumstances, the blood is a sterile environment ...

Definitions Bacteremia: Presence of bacteria in the blood Under normal circumstances, the blood is a sterile environment ...

| PowerPoint PPT presentation | free to download

Top 10 dangerous Drug Interactions PowerPoint PPT Presentation

Top 10 dangerous Drug Interactions - AMDA and ASCP summarised top 10 danferous drug interactions involving Warfarin, ACE inhibitors, Digoxin or Theophylline with other drugs

AMDA and ASCP summarised top 10 danferous drug interactions involving Warfarin, ACE inhibitors, Digoxin or Theophylline with other drugs

| PowerPoint PPT presentation | free to view

Anti-Infective Drug Products and Drug Safety and Risk Management Advisory Committees Meeting PowerPoint PPT Presentation

Anti-Infective Drug Products and Drug Safety and Risk Management Advisory Committees Meeting - amoxicillin/clavulanate. cefdinir, cefditoren pivoxil, cefpodoxime proxetil, loracarbef, ... Amoxicillin. Infections of the ear, nose, and throat due to ...

amoxicillin/clavulanate. cefdinir, cefditoren pivoxil, cefpodoxime proxetil, loracarbef, ... Amoxicillin. Infections of the ear, nose, and throat due to ...

| PowerPoint PPT presentation | free to view

Lecture 7: Antimicrobial therapy Definition Antibiotics are PowerPoint PPT Presentation

Lecture 7: Antimicrobial therapy Definition Antibiotics are - Lecture 7: Antimicrobial therapy Definition Antibiotics are antibacterial substances produced by various species of microorganisms (bacteria, fungi, and actinomycetes ...

Lecture 7: Antimicrobial therapy Definition Antibiotics are antibacterial substances produced by various species of microorganisms (bacteria, fungi, and actinomycetes ...

| PowerPoint PPT presentation | free to view

Mechanisms of Action Antifungal Drugs PowerPoint PPT Presentation

Mechanisms of Action Antifungal Drugs - Attaches to ergosterol disrupts cell membrane cell lysis ... Big pharmaceutical companies. Smaller ($) market for anti-infectives ...

Attaches to ergosterol disrupts cell membrane cell lysis ... Big pharmaceutical companies. Smaller ($) market for anti-infectives ...

| PowerPoint PPT presentation | free to view

Antibiotics - NAMA, N-acetyl-muramic acid; NAGA, N-acetyl-glucosamine. ... a new subunit of N-acetylmuramic acid (NAMA) and N-acetylglucosamine (NAGA) ...

NAMA, N-acetyl-muramic acid; NAGA, N-acetyl-glucosamine. ... a new subunit of N-acetylmuramic acid (NAMA) and N-acetylglucosamine (NAGA) ...

| PowerPoint PPT presentation | free to download

Glycoside Antibiotics PowerPoint PPT Presentation

Glycoside Antibiotics - Distort the A site, causing codon-anticodon mismatching ... damage hair cells of Crista Ampullaris (vestibular branch of 8th cranial nerve) ...

Distort the A site, causing codon-anticodon mismatching ... damage hair cells of Crista Ampullaris (vestibular branch of 8th cranial nerve) ...

| PowerPoint PPT presentation | free to view

Antibiotic Resistance Relevance to Dentistry PowerPoint PPT Presentation

Antibiotic Resistance Relevance to Dentistry - Cephalosporin 14% Macrolide or strepogramins 11% Metronidazole 17 ... Cephalosporins. Tetracycline resistance is encoded on the tet gene ...

Cephalosporin 14% Macrolide or strepogramins 11% Metronidazole 17 ... Cephalosporins. Tetracycline resistance is encoded on the tet gene ...

| PowerPoint PPT presentation | free to view

Making Better Decisions About Your Care: Special considerations for patients with myasthenia gravis PowerPoint PPT Presentation

Making Better Decisions About Your Care: Special considerations for patients with myasthenia gravis - Making Better Decisions About Your Care: Special considerations for patients ... Rapid tapering of steroids or immune suppressant drugs. Beginning steroid treatment ...

Making Better Decisions About Your Care: Special considerations for patients ... Rapid tapering of steroids or immune suppressant drugs. Beginning steroid treatment ...

| PowerPoint PPT presentation | free to view

A Review of Antibiotic Classes PowerPoint PPT Presentation

A Review of Antibiotic Classes - Group streptococci Salmonella, Shigella. viridans streptococci some E. coli. Enterococcus sp. ... Salmonella (amoxicillin) or Shigella (ampicillin) infections ...

Group streptococci Salmonella, Shigella. viridans streptococci some E. coli. Enterococcus sp. ... Salmonella (amoxicillin) or Shigella (ampicillin) infections ...

| PowerPoint PPT presentation | free to view

Inhibitory and bactericidal concentrations of current and new antibiotics for Methicillinresistant S PowerPoint PPT Presentation

Inhibitory and bactericidal concentrations of current and new antibiotics for Methicillinresistant S - Inhibitory and bactericidal concentrations of current and new antibiotics for ... Darlene Miller, DHSc. Neither author has any financial disclosures. ...

Inhibitory and bactericidal concentrations of current and new antibiotics for ... Darlene Miller, DHSc. Neither author has any financial disclosures. ...

| PowerPoint PPT presentation | free to view

Pharmacodynamie d'efficacit in vitro in vivo PowerPoint PPT Presentation

Pharmacodynamie d'efficacit in vitro in vivo - ne s'applique qu'aux bact ries sensibles ou interm diaires en vue ... 'ils sont bact ricides, les temps-d pendants agissent leur vitesse maximale (qui est ...

ne s'applique qu'aux bact ries sensibles ou interm diaires en vue ... 'ils sont bact ricides, les temps-d pendants agissent leur vitesse maximale (qui est ...

| PowerPoint PPT presentation | free to view

Bez nadpisu - appropriate therapy for the treatment of salmonella-derived enteritis ... activity against Proteus mirabilis, E. coli, and Klebsiella Pneumoniae (the acronym ...

appropriate therapy for the treatment of salmonella-derived enteritis ... activity against Proteus mirabilis, E. coli, and Klebsiella Pneumoniae (the acronym ...

| PowerPoint PPT presentation | free to view

CLINICAL PHARMACOLOGY OF ANTIBACTERIAL AND ANTIVIRAL AGENTS PowerPoint PPT Presentation

CLINICAL PHARMACOLOGY OF ANTIBACTERIAL AND ANTIVIRAL AGENTS - CLINICAL PHARMACOLOGY OF ANTIBACTERIAL AND ANTIVIRAL AGENTS ANTIBACTERIAL DRUGS. Mechanisms of Action 1. Inhibition of bacterial cell wall synthesis or activation of ...

CLINICAL PHARMACOLOGY OF ANTIBACTERIAL AND ANTIVIRAL AGENTS ANTIBACTERIAL DRUGS. Mechanisms of Action 1. Inhibition of bacterial cell wall synthesis or activation of ...

| PowerPoint PPT presentation | free to view

Macrolide antibiotics PowerPoint PPT Presentation

Macrolide antibiotics - Macrolide antibiotics Static, contain lactone ring + sugars (12-22 carbon lactone ring linked to sugars) Include: Erythromycin; Clarithromycin; Azithromycin

Macrolide antibiotics Static, contain lactone ring + sugars (12-22 carbon lactone ring linked to sugars) Include: Erythromycin; Clarithromycin; Azithromycin

| PowerPoint PPT presentation | free to download

MULTIDRUG RESISTANT TUBERCULOSIS PowerPoint PPT Presentation

MULTIDRUG RESISTANT TUBERCULOSIS - Pyrazinamide 1.0 - 1.05 gm at bed time. Ethambutol 0.8 - 1.2 gm. At bed time. Ethionamide 0.5 - 0.75 gm. two time a day. Cycloserine 0.5 - 0.75 gm. two time a day ...

Pyrazinamide 1.0 - 1.05 gm at bed time. Ethambutol 0.8 - 1.2 gm. At bed time. Ethionamide 0.5 - 0.75 gm. two time a day. Cycloserine 0.5 - 0.75 gm. two time a day ...

| PowerPoint PPT presentation | free to view

Les Nouveaux Antibiotiques PowerPoint PPT Presentation

Les Nouveaux Antibiotiques - Les probl matiques actuelles. Exp rience limit e des cas s v res (pas ... Les probl matiques actuelles. Des tudes men es chez des patients peu s v res (APACHE II ...

Les probl matiques actuelles. Exp rience limit e des cas s v res (pas ... Les probl matiques actuelles. Des tudes men es chez des patients peu s v res (APACHE II ...

| PowerPoint PPT presentation | free to view

Drug Interactions of Antidiabetics (Part 8): Interactions of DPP 4 Inhibitors PowerPoint PPT Presentation

Drug Interactions of Antidiabetics (Part 8): Interactions of DPP 4 Inhibitors - DPP 4 Inhibitors interact with CYP3A4 inducers, CYP3A4 inhibitors and P-Glycoproteins inhibitors.

DPP 4 Inhibitors interact with CYP3A4 inducers, CYP3A4 inhibitors and P-Glycoproteins inhibitors.

| PowerPoint PPT presentation | free to view

Postmarketing Safety Data PowerPoint PPT Presentation

Postmarketing Safety Data - The patient was without symptoms until the next afternoon when the patient's ... Sonography 'there were no congested bile ducts and the liver was morphological ...

The patient was without symptoms until the next afternoon when the patient's ... Sonography 'there were no congested bile ducts and the liver was morphological ...

| PowerPoint PPT presentation | free to view

Unit - Critical Analysis of the Risk/Benefit Ratio Related to the Use of Guidelines for ... In: Haslett C, Chilvers ER, Boon NA, Colledge NR, Hunter JAA, eds. ...

Critical Analysis of the Risk/Benefit Ratio Related to the Use of Guidelines for ... In: Haslett C, Chilvers ER, Boon NA, Colledge NR, Hunter JAA, eds. ...

| PowerPoint PPT presentation | free to download

Place des Nouveaux Antibiotiques PowerPoint PPT Presentation

Place des Nouveaux Antibiotiques - Place des Nouveaux Antibiotiques Docteur MF LUTZ Les penems :Doripenem DORIBAX Action PSDP Meilleure action anti pseudomonas par rapport l Imipenem (CMI 2-4X ...

Place des Nouveaux Antibiotiques Docteur MF LUTZ Les penems :Doripenem DORIBAX Action PSDP Meilleure action anti pseudomonas par rapport l Imipenem (CMI 2-4X ...

| PowerPoint PPT presentation | free to view

Other Causes of Rhinosinusitis PowerPoint PPT Presentation

Other Causes of Rhinosinusitis - Endoscopic view of middle meatal polyp that has caused recurrent acute rhinosinusitis ... Small polyp not visible on anterior rhinoscopy ...

Endoscopic view of middle meatal polyp that has caused recurrent acute rhinosinusitis ... Small polyp not visible on anterior rhinoscopy ...

| PowerPoint PPT presentation | free to view

Protein synthesis inhibitors: PowerPoint PPT Presentation

Protein synthesis inhibitors: - MLS-B Clinical uses DOC for Corynebacterium infection (diphteria*, corynebacterial sepsis, erythasma) Respiratory, neonatal, ocular, ...

MLS-B Clinical uses DOC for Corynebacterium infection (diphteria*, corynebacterial sepsis, erythasma) Respiratory, neonatal, ocular, ...

| PowerPoint PPT presentation | free to view

Diltiazem Drug Interactions: A Quality Assessment of GeneMedRx PowerPoint PPT Presentation

Diltiazem Drug Interactions: A Quality Assessment of GeneMedRx - Objectives for this project Research known pharmacokinetic and pharmacodynamic interactions between ... Pharmacokinetic interaction between tacrolimus and ...

Objectives for this project Research known pharmacokinetic and pharmacodynamic interactions between ... Pharmacokinetic interaction between tacrolimus and ...

| PowerPoint PPT presentation | free to download

Diltiazem Drug Interactions: A Quality Assessment of GeneMedRx - The cyclosporine-sparing effects of diltiazem in renal transplantation. Transplant Proc 1989;21:3955-3957. PMID 2609415. McLachlan AJ & Tett SE.

The cyclosporine-sparing effects of diltiazem in renal transplantation. Transplant Proc 1989;21:3955-3957. PMID 2609415. McLachlan AJ & Tett SE.

| PowerPoint PPT presentation | free to view

Review of post-marketing safety of Factive (gemifloxacin) PowerPoint PPT Presentation

Review of post-marketing safety of Factive (gemifloxacin) - Stevens-Johnson syndrome (SJS) Toxic epidermal necrolysis (TEN) ... Evelyn R. Farinas, R.Ph., M.G.A.. Melissa Truffa, R.Ph. Syed Rizwanuddin Ahmad, M.D., M.P.H. ...

Stevens-Johnson syndrome (SJS) Toxic epidermal necrolysis (TEN) ... Evelyn R. Farinas, R.Ph., M.G.A.. Melissa Truffa, R.Ph. Syed Rizwanuddin Ahmad, M.D., M.P.H. ...

| PowerPoint PPT presentation | free to view

Infectious Diseases Update2008 PowerPoint PPT Presentation

Infectious Diseases Update2008 - 7 yo WF presents with 6 days of fever and now can't walk, ... 32 g/mL; Clarithromycin, 32 g/mL; Azithromycin, 32 g/mL; Clindamycin, 64 g/mL;Tetracycline. ...

7 yo WF presents with 6 days of fever and now can't walk, ... 32 g/mL; Clarithromycin, 32 g/mL; Azithromycin, 32 g/mL; Clindamycin, 64 g/mL;Tetracycline. ...

| PowerPoint PPT presentation | free to view

Parameter f - Title: Folie 1 Author: Rainer Gattringer Last modified by: Rainer Gattringer Created Date: 11/4/2006 8:33:55 PM Document presentation format: Bildschirmpr sentation

Title: Folie 1 Author: Rainer Gattringer Last modified by: Rainer Gattringer Created Date: 11/4/2006 8:33:55 PM Document presentation format: Bildschirmpr sentation

| PowerPoint PPT presentation | free to download

Telithromycin PowerPoint PPT Presentations